阿茲海默症臨床試驗長年處於高失敗率、低回報的泥沼。本集邀請你從科學的根本重新審視：透過整合基因體、蛋白體、代謝體等多體學資料，科學家如何重建疾病機制地圖，並意外發現可重定位的癌症藥物組合，有望為退化性神經疾病注入新曙光。
Alzheimer’s trials have long suffered from high failure rates. In this deep-dive episode of XioTalks, we explore how multi-omics is reshaping our understanding of disease pathways—and how it’s leading researchers to unexpected therapeutic combinations, including repurposed oncology drugs.
-📝https://doi.org/10.1016/j.cell.2025.06.035-
TBAL 台灣活性脂質股份有限公司
官網 https://www.t-bal.com/
粉絲臉書團 https://www.facebook.com/TBAL2017
YOUTUBE https://www.youtube.com/@Taiwan-BioActive-Lipid
The recipient's phone：+886-4-2247-6758
Customer service email：t-bal_2@t-bal.com.tw
Fax：04-2217-5362
LINE ID：@722hneuu
